{
    "root": "a78e0fc3-6693-4308-82ed-11084d6d5d62",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": "Indomethacin",
    "value": "20250328",
    "ingredients": [
        {
            "name": "INDOMETHACIN",
            "code": "XXE1CET956"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        }
    ],
    "indications": "indomethacin capsules indicated : \u2022 moderate severe rheumatoid arthritis including acute flares chronic disease \u2022 moderate severe ankylosing spondylitis \u2022 moderate severe osteoarthritis \u2022 acute painful shoulder ( bursitis and/or tendinitis ) \u2022 acute gouty arthritis",
    "contraindications": "\u2022 lowest effective shortest duration consistent individual patient treatment goals ( 2.1 ) \u2022 moderate severe rheumatoid arthritis including acute flares chronic disease ; moderate severe ankylosing spondylitis ; moderate severe osteoarthritis indomethacin capsules 25 mg two three times day ( 2.2 ) \u2022 acute painful shoulder ( bursitis and/or tendinitis ) 75 mg 150 mg daily 3 4 divided doses ( 2.3 ) \u2022 acute gouty arthritis indomethacin capsules 50 mg three times day ( 2.4 )",
    "warningsAndPrecautions": "indomethacin capsules usp , 25 mg size ' 3 ' hard gelatin capsules , opaque light green cap imprinted ' h ' opaque light green body imprinted '103 ' , containing white off-white powder . supplied follows : ndc 71335-1250-01 - discontinued / med 03-29-2023 indomethacin capsules usp , 50 mg size ' 1 ' hard gelatin capsules , opaque light green cap imprinted ' h ' opaque light green body imprinted '104 ' , containing white off-white powder . supplied follows : ndc 71335-1568-1 21 capsule bottle ndc 71335-1568-2 42 capsule bottle ndc 71335-1568-3 30 capsule bottle ndc 71335-1568-4 60 capsule bottle ndc 71335-1568-5 90 capsule bottle ndc 71335-1568-6 14 capsule bottle ndc 71335-1568-7 20 capsule bottle store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . protect light.dispense tight , light-resistant container defined usp using child-resistant closure . repackaged/relabeled : bryant ranch prepack , inc.burbank , ca 91504",
    "adverseReactions": "indomethacin capsules contraindicated following patients : \u2022 known hypersensitivity ( e.g . , anaphylactic serious skin ) indomethacin components product [ ( 5.7 , 5.9 ) ] \u2022 history asthma , urticaria , allergic-type taking aspirin nsaids . severe , sometimes fatal , anaphylactic nsaids reported patients [ ( 5.7 , 5.8 ) ] \u2022 setting coronary artery bypass graft ( cabg ) surgery [ ( 5.1 ) ]",
    "indications_original": "Indomethacin Capsules are indicated for:  \u2022\u00a0Moderate to severe rheumatoid arthritis including acute flares of chronic disease \u2022\u00a0Moderate to severe ankylosing spondylitis \u2022\u00a0Moderate to severe osteoarthritis \u2022\u00a0Acute painful shoulder (bursitis and/or tendinitis) \u2022\u00a0Acute gouty arthritis",
    "contraindications_original": "\u2022\u00a0Use the lowest effective dosage for shortest duration consistent with individual patient treatment goals ( 2.1 ) \u2022\u00a0The dosage for moderate to severe rheumatoid arthritis including acute flares of chronic disease; moderate to severe ankylosing spondylitis; and moderate to severe osteoarthritis is indomethacin capsules 25 mg two or three times a day ( 2.2 ) \u2022\u00a0The dosage for acute painful shoulder (bursitis and/or tendinitis) is 75 mg to 150 mg daily in 3 or 4 divided doses ( 2.3 ) \u2022\u00a0The dosage for acute gouty arthritis is indomethacin capsules 50 mg three times a day ( 2.4 )",
    "warningsAndPrecautions_original": "Indomethacin capsules USP, 25 mg are size '3' hard gelatin capsules, with opaque light green cap imprinted with 'H' and opaque light green body imprinted with '103', containing white to off-white powder. They are supplied as follows:\n                  \n                  \n                     \n                        NDC 71335-1250-01 - Discontinued / MED\u00a003-29-2023\n                     \n                  \n                  \n                     Indomethacin capsules USP, 50 mg are size '1' hard gelatin capsules, with opaque light green cap imprinted with 'H' and opaque light green body imprinted with '104', containing white to off-white powder. They are supplied as follows:\n                  \n                  \n                     NDC 71335-1568-1 21 CAPSULE in a BOTTLE\n                     NDC 71335-1568-2 42 CAPSULE in a BOTTLE\n                     NDC 71335-1568-3 30 CAPSULE in a BOTTLE\n                     NDC 71335-1568-4 60 CAPSULE in a BOTTLE\n                     NDC 71335-1568-5 90 CAPSULE in a BOTTLE\n                     NDC 71335-1568-6 14 CAPSULE in a BOTTLE\n                     NDC 71335-1568-7 20 CAPSULE in a BOTTLE\n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature]. Protect from light.Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions_original": "Indomethacin Capsules are contraindicated in the following patients:  \u2022\u00a0Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to indomethacin or any components of the drug product [see Warnings and Precautions (5.7, 5.9)]  \u2022\u00a0History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients [see Warnings and Precautions (5.7, 5.8)]  \u2022\u00a0In the setting of coronary artery bypass graft (CABG) surgery [see Warnings and Precautions (5.1)]"
}